title: Exploitation of chick embryo environments to reprogram MYCN-amplified neuroblastoma cells to a benign phenotype, lacking detectable MYCN expression.
abstract: Neuroblastoma is a paediatric cancer that arises from the sympathetic ganglia (SG) or adrenal gland. Tumours that occur in patients under 18 months of age have a particularly good prognosis and frequently undergo spontaneous regression. This led to the hypothesis that developmental cues in the youngest patients may prompt belated differentiation and/or apoptosis of the tumour cells. To test our hypothesis, we have injected MYCN-amplified neuroblastoma cells into the extra embryonic veins of chick embryos at embryonic day 3 (E3) and E6 and analysed the response of these Kelly cells at E10 and E14. Amplification of the MYCN gene occurs in up to 30% of tumours and is normally associated with a very poor prognosis. Kelly cells injected at E3 follow neural crest pathways and integrate into neural locations such as SG and the enteric nervous system although never into the adrenal gland. Additionally they migrate to non-neural locations such as the heart, meninges, jaw regions and tail. The cells respond to their respective microenvironments and in SG, some cells differentiate, they show reduced cell division and crucially all cells have undetectable MYCN expression by E10. In non-neural locations, cells form more rapidly dividing clumps and continue to express MYCN. The downregulation of MYCN is dependent on continuous and direct interaction with the sympathetic ganglion environment. We propose that the MYCN-amplicon in the Kelly cells retains the ability to correctly interpret the environmental cues leading to downregulation of MYCN.
authors.affiliation: Department of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
authors.forename: R
authors.initials: R
authors.lastname: Carter
authors.forename: D
authors.initials: D
authors.lastname: Mullassery
authors.forename: V
authors.initials: V
authors.lastname: See
authors.forename: S
authors.initials: S
authors.lastname: Theocharatos
authors.forename: B
authors.initials: B
authors.lastname: Pizer
authors.forename: P D
authors.initials: PD
authors.lastname: Losty
authors.forename: E
authors.initials: E
authors.lastname: Jesudason
authors.forename: D J
authors.initials: DJ
authors.lastname: Moss
references.citation: Mol Cell Biol. 1994 Jan;14(1):759-67
references.pmid: 8264643
references.citation: J Biol Chem. 2004 Feb 13;279(7):5110-7
references.pmid: 14645238
references.citation: Oncogene. 2010 May 6;29(18):2681-90
references.pmid: 20190806
references.citation: Int J Dev Biol. 2009;53(8-10):1563-8
references.pmid: 19924629
references.citation: Nat Rev Cancer. 2007 Apr;7(4):246-55
references.pmid: 17384580
references.citation: Oncogene. 2010 Mar 4;29(9):1249-59
references.pmid: 20101214
references.citation: Melanoma Res. 2007 Feb;17(1):17-30
references.pmid: 17235238
references.citation: Nat Genet. 1999 Feb;21(2):220-4
references.pmid: 9988278
references.citation: Development. 1997 May;124(10):1953-62
references.pmid: 9169842
references.citation: Hum Gene Ther. 2002 May 1;13(7):803-13
references.pmid: 11975847
references.citation: Cancer Res. 2001 Apr 1;61(7):2968-73
references.pmid: 11306475
references.citation: Proc Natl Acad Sci U S A. 2005 Feb 1;102(5):1643-8
references.pmid: 15665100
references.citation: Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3752-7
references.pmid: 16505384
references.citation: J Biol Chem. 2007 Dec 21;282(51):37170-80
references.pmid: 17951258
references.citation: J Biol Chem. 2003 Jan 31;278(5):2983-9
references.pmid: 12438307
references.citation: Trends Cardiovasc Med. 1999 Oct;9(7):214-20
references.pmid: 10881754
references.citation: Pediatr Blood Cancer. 2008 Apr;50(4):806-11
references.pmid: 17554788
references.citation: J Neurosci. 1989 Jan;9(1):13-24
references.pmid: 2643681
references.citation: Lancet. 1994 Sep 24;344(8926):869-70
references.pmid: 7916408
references.citation: Semin Cancer Biol. 2011 Oct;21(4):256-66
references.pmid: 21849159
references.citation: J Clin Pathol. 2006 Sep;59(9):927-9
references.pmid: 16565222
references.citation: Curr Pharm Des. 2010;16(4):431-9
references.pmid: 20236072
references.citation: Lab Invest. 1996 Nov;75(5):659-75
references.pmid: 8941212
references.citation: Clin Cancer Res. 2009 May 15;15(10):3244-50
references.pmid: 19417027
references.citation: Hum Mol Genet. 2011 Apr 15;20(8):1488-501
references.pmid: 21258086
references.citation: Nucleic Acids Res. 2008 Aug;36(13):4222-32
references.pmid: 18583365
references.citation: Am J Surg Pathol. 2006 Feb;30(2):249-57
references.pmid: 16434901
references.citation: Int J Oncol. 2008 Nov;33(5):1081-9
references.pmid: 18949372
references.citation: Dev Biol. 2006 Oct 15;298(2):335-43
references.pmid: 16928368
references.citation: Cancer Res. 2011 Jan 15;71(2):404-12
references.pmid: 21123453
references.citation: Biochem Biophys Res Commun. 2009 Dec 4;390(1):21-6
references.pmid: 19766596
references.citation: Cancer Lett. 2005 Oct 18;228(1-2):21-7
references.pmid: 15927364
references.citation: Clin Exp Metastasis. 2009;26(8):1033-47
references.pmid: 19842048
references.citation: J Virol. 1997 Aug;71(8):5871-7
references.pmid: 9223476
references.citation: BMC Dev Biol. 2011 Jan 03;11:1
references.pmid: 21194500
references.citation: Dev Biol. 1987 Mar;120(1):198-214
references.pmid: 3817289
references.citation: Cancer Lett. 2003 Jul 18;197(1-2):81-6
references.pmid: 12880964
references.citation: Cell Tissue Res. 1999 Nov;298(2):185-206
references.pmid: 10550645
references.citation: Pediatr Blood Cancer. 2011 Dec 15;57(7):1254-60
references.pmid: 21523901
references.citation: Proc Natl Acad Sci U S A. 1986 Aug;83(16):5929-33
references.pmid: 2426708
references.citation: Br J Cancer. 2011 Jul 12;105(2):296-303
references.pmid: 21654684
references.citation: Development. 1998 Nov;125(21):4335-47
references.pmid: 9753687
references.citation: J Biol Chem. 2002 Jan 18;277(3):1967-73
references.pmid: 11711535
references.citation: Semin Cancer Biol. 2004 Oct;14(5):365-73
references.pmid: 15288262
references.citation: J Clin Oncol. 2000 Feb;18(3):477-86
references.pmid: 10653863
references.citation: Int J Oncol. 2010 Oct;37(4):983-91
references.pmid: 20811720
references.citation: Arch Dis Child Educ Pract Ed. 2009 Dec;94(6):177-85
references.pmid: 19933390
references.citation: Cell Tissue Res. 2005 Jan;319(1):1-13
references.pmid: 15565470
references.citation: N Engl J Med. 2010 Jun 10;362(23):2202-11
references.pmid: 20558371
references.citation: Angiogenesis. 2008;11(4):311-9
references.pmid: 18780151
references.citation: Int J Cancer. 2008 Feb 1;122(3):526-33
references.pmid: 17943733